Search results
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
Oct 20, 2021 · As if his own record weren’t bad enough, former coal baron and current West Virginia senator Joe Manchin’s daughter Heather Bresch — who doubles as a major donor to Joe — is a price-gouging drug profiteer who has played a central role in her father’s destructive political career.
Jan 27, 2017 · Last September, Mylan CEO Heather Bresch was called before Congress to explain why EpiPen’s price had soared from about $103.50 in 2009 to more than $608.61 in 2016.
Jul 29, 2019 · During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way. And now, Bresch says she's stepping aside...
Sep 7, 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according...
Mar 17, 2022 · With a final hearing set for July, the deal puts Heather Bresch, Manchin’s daughter and Mylan’s former CEO, on track to dodge legal repercussion from a yearslong saga involving allegations of...
Aug 24, 2016 · Heather Bresch's career has risen along with her father's, a fact that has not gone unnoticed by her critics. But Bresch's corporate rise is also a modern-day success story.
About Heather Bresch. In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year.
Feb 28, 2022 · Then-Mylan CEO Heather Bresch, daughter of U.S. Sen. Joe Manchin of West Virginia, takes her seat on Capitol Hill on Sept. 21, 2016, before testifying before the House Oversight Committee on...
Sep 21, 2016 · Heather Bresch, the CEO of Mylan — which makes the EpiPen — testified in front of the House Oversight and Government Reform Committee about the drug's price Wednesday.
Related searches
